Correlation Between Inhibrx and GlycoMimetics
Can any of the company-specific risk be diversified away by investing in both Inhibrx and GlycoMimetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and GlycoMimetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and GlycoMimetics, you can compare the effects of market volatilities on Inhibrx and GlycoMimetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of GlycoMimetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and GlycoMimetics.
Diversification Opportunities for Inhibrx and GlycoMimetics
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Inhibrx and GlycoMimetics is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and GlycoMimetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GlycoMimetics and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with GlycoMimetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GlycoMimetics has no effect on the direction of Inhibrx i.e., Inhibrx and GlycoMimetics go up and down completely randomly.
Pair Corralation between Inhibrx and GlycoMimetics
Given the investment horizon of 90 days Inhibrx is expected to under-perform the GlycoMimetics. But the stock apears to be less risky and, when comparing its historical volatility, Inhibrx is 1.86 times less risky than GlycoMimetics. The stock trades about -0.05 of its potential returns per unit of risk. The GlycoMimetics is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 33.00 in GlycoMimetics on December 1, 2024 and sell it today you would lose (6.00) from holding GlycoMimetics or give up 18.18% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Inhibrx vs. GlycoMimetics
Performance |
Timeline |
Inhibrx |
GlycoMimetics |
Inhibrx and GlycoMimetics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inhibrx and GlycoMimetics
The main advantage of trading using opposite Inhibrx and GlycoMimetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, GlycoMimetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GlycoMimetics will offset losses from the drop in GlycoMimetics' long position.Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
GlycoMimetics vs. Mineralys Therapeutics, Common | GlycoMimetics vs. Foghorn Therapeutics | GlycoMimetics vs. Inventiva Sa | GlycoMimetics vs. Dyne Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |